Clinical Trial Update: Clinical Trial for PB-119 in Healthy Subjects (Phase I) [Phase 1]

View source ↗

Summary

A Phase I clinical trial of PB-119 in healthy subjects sponsored by PegBio Co., Ltd. has completed, with Type 2 diabetes listed as the condition.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• PB-119 (PB-119)

Snippet

Sponsor: PegBio Co., Ltd. | Conditions: Type II Diabetes | Phase 1 | Status: COMPLETED